Gelteq Limited Ordinary Shares
NASDAQ: GELS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Nathan Jacob Givoni
- Employees
- 7
- Headquarters
- Caulfield, Australia
- IPO year
- 2024
- Market cap
- $6.3M
- Website
- https://www.gelteq.com
Loading GELS…
Loading profile data…Frequently asked questions about GELS
What does Gelteq Limited Ordinary Shares (GELS) do?
Gelteq Limited, established in 2017 and based in Caulfield, Australia, specializes in creating and commercializing advanced gel-based delivery methods for both human and animal use. The company offers customizable, white-label gel formulations that can be applied to a broad array of goods, such as prescribed pharmaceuticals, non-prescription rem...
Where does GELS trade?
Gelteq Limited Ordinary Shares (GELS) trades on the NASDAQ Global Select.
What sector is GELS in?
Gelteq Limited Ordinary Shares (GELS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Gelteq Limited Ordinary Shares?
Nathan Jacob Givoni is the chief executive officer of Gelteq Limited Ordinary Shares (GELS).
Where is Gelteq Limited Ordinary Shares headquartered?
Gelteq Limited Ordinary Shares is headquartered in Australia.
Does GELS pay a dividend?
Gelteq Limited Ordinary Shares (GELS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did GELS go public?
Gelteq Limited Ordinary Shares (GELS) completed its initial public offering in 2024.